SGALPBE@RC2507A (10497.HK)

Compare

0.198

-0.037

(-15.74%)

At close: 9:33:58 AM GMT+8

Stock market today: Dow, S&P 500, Nasdaq futures point to rebound from Fed-fueled rout

Stocks are looking to bounce back from their worst day since the summer.

Yahoo Finance 8 minutes ago

NQ=F

ES=F

^IXIC
Fed cuts rates by quarter point, scales back cuts for 2025

The Federal Reserve reduced interest rates by a quarter percentage point Wednesday and scaled back the number of cuts it expects to make next year.

Yahoo Finance 23 hours ago

^DJI

^GSPC
Stock market today: Dow, S&P 500, Nasdaq clobbered as Fed, Powell signal fewer rate cuts in 2025

Stocks eyed a rebound Wednesday, with the blue-chip Dow looking to snap its longest losing streak since 1978

Yahoo Finance 15 hours ago

^DJI

^GSPC

YM=F
Your 2025 portfolio strategy can't rely on more rate cuts: Strategist

US stocks (^DJI,^GSPC, ^IXIC) are trading lower after the Federal Reserve announced a 25 basis point cut and said it expects to deliver two cuts in 2025. Innovator Capital Management head of research and investment strategy Tim Urbanowicz sits down with Market Domination Overtime co-hosts Julie Hyman and Josh Lipton to examine the market reaction to the Fed announcement. "There is such high expectations across the board" for the market in 2025, Urbanowicz says, explaining, "the expectation for the Fed [is] going to continue on this aggressive pace of cutting without any economic pain. It's great if it plays out, but today, as you see, those expectations pulled back, you see the market pull back." While Fed Chair Jerome Powell indicated that the US economy is strong, justifying the 25 basis point cut at the December meeting, Urbanowicz says, "the big fear is a reacceleration in inflation." The strategist notes that recent data signals inflation progress is stalling, just ahead of President-elect Donald Trump's second term. "I think they're getting nervous about the new administration coming in," Urbanowicz says, noting that Trump's policy proposals, like tariffs and mass deportations, are expected to be inflationary. Overall, the strategist says the market reaction to the Fed meeting underlines that "investors need to be very cautious on their expectations for the Fed ... investors need to really disconnect the need for risk management and interest rates in their portfolio in 2025," as it seems rates will be staying higher for longer than initially expected. To watch more expert insights and analysis on the latest market action, check out more Market Domination Overtime here. This post was written by Naomi Buchanan.

Yahoo Finance Video 15 hours ago

^DJI

^GSPC

^IXIC
Dow, S&P 500, Nasdaq sell off after Fed's 25 bps cut

All three of the market averages (^DJI, ^IXIC, ^GSPC) are selling off following the Federal Reserve's latest interest rate cut on Wednesday. This negative close marks the tenth straight losing session for the Dow Jones Industrial Average. The Nasdaq Composite lags the most, closing by 3.56% lower. Market Domination Overtime host Julie Hyman and Yahoo Finance markets and data editor Jared Blikre recap the day's market losses following the Fed's December rate cut. To watch more expert insights and analysis on the latest market action, check out more Market Domination Overtime here. This post was written by Luke Carberry Mogan.

Yahoo Finance Video 15 hours ago

^RUT

^SP500EW

^DJI
Why this strategist sees a 'multi-month pause' from the Fed

The Federal Reserve implemented a 25 basis point rate cut Wednesday afternoon, sending stock markets (^DJI, ^IXIC, ^GSPC) lower. Roth Capital Partners chief economist & macro strategist Michael Darda joins Market Domination to provide insights into the central bank's decision. Darda says the rate cut was "expected" but notes the updated dot plot projections contained a hawkish tone. He anticipates a "multi-month pause" in rate cuts, citing Federal Reserve Chair Powell's indication that the economy is outperforming initial expectations from September. "What's really strange about the current backdrop is ... the labor market is cooling," Darda explains. He highlights that private employment growth is at "half the level that we were seeing pre-pandemic," and the unemployment rate showed early recessionary signals by "hooking upwards" during the summer. Despite this, Darda notes that overall, economic growth remains robust, with fourth quarter GDP tracking estimates in the 3% range. "People look at that, and they look at the stock market ... and they kind of scratch their head thinking, 'what is the sense of urgency here? Why is the Fed doing 100 basis points of cuts when everything seems to be fine?'" Darda tells Yahoo Finance. To watch more expert insights and analysis on the latest market action, check out more Market Domination here. This post was written by Angel Smith

Yahoo Finance Video 16 hours ago

^DJI

^GSPC

^IXIC
Oklo strikes nuclear power deal with Switch, stock jumps

Oklo (OKLO) stock is rising Wednesday following the company's announcement of a strategic partnership with data center operator Switch. The nuclear power deal involves Oklo developing 12 gigawatts of advanced nuclear power to supply Switch's facilities across the United States through 2044. Yahoo Finance anchors Madison Mills and Brad Smith dive into the details. To watch more expert insights and analysis on the latest market action, check out more Wealth here. This post was written by Angel Smith

Yahoo Finance Video 19 hours ago

OKLO
Biden reignites talk of a stock-trading ban for lawmakers. Familiar hurdles remain.

President Joe Biden this week announced an endorsement of a stock-trading ban for US lawmakers, making a last-minute entry into an issue that has bedeviled Capitol Hill for years.

Yahoo Finance 22 hours ago

^DJI

^GSPC
Fed rate decision, Dow pressured, Nissan-Honda: 3 Things

US stock futures (ES=F, NQ=F, YM=F) inch higher Wednesday morning in anticipation of the Federal Reserve's interest rate decision this afternoon. Wall Street currently anticipates the central bank to cut by 25 basis points. After closing lower for the ninth straight session on Tuesday, the Dow Jones Industrial Average (^DJI) is seeing its longest streak of losses since February 1978, weighed down by UnitedHealth Group (UNH), Nvidia (NVDA), and Sherwin-Williams (SHW). Japanese automakers Nissan (NSANY, 7201.T) and Honda (HMC, 7267.T) confirmed reports that they are currently in talks for a possible merger. To watch more expert insights and analysis on the latest market action, check out more Morning Brief here. This post was written by Luke Carberry Mogan.

Yahoo Finance Video 22 hours ago

NQ=F

NVDA

SHW
Micron downgraded at BofA on gross margin, pricing headwinds

Investing.com -- Bank of America (BofA) downgraded Micron Technology (NASDAQ:MU) shares to Neutral from Buy, citing a weaker-than-expected gross margin (GM) outlook for the second and third fiscal quarters.

Investing.com 15 minutes ago

MU
Cognition Therapeutics announces results in Phase 2 study of CT1812

Cognition Therapeutics (CGTX) announced topline results from the exploratory Phase 2 ‘SHIMMER’ study demonstrating CT1812 produced strong therapeutic responses across behavioral, functional, cognitive, and movement measures in patients with dementia with Lewy bodies. Designed as a signal-finding study, the SHIMMER Phase 2 study enrolled 130 patients with mild-to-moderate DLB who were randomized to receive one of two oral doses of CT1812 or placebo daily for six months. Results indicate the study

TipRanks 19 minutes ago

CGTX
Vertex Non-Opioid Drug Doesn't Best Placebo In Back Pain Study. The Stock Is Plunging.

Vertex Pharmaceuticals reported that its non-opioid drug reduced back pain significantly. But Vertex stock plunged as a placebo showed similar results.

Investor's Business Daily 26 minutes ago

VRTX
Dow Rebounding After Fed Scare Triggers Huge Selloff. Index on 10-Day Losing Streak.

U.S. stocks looked set to pare back some of their losses on Thursday after Federal Reserve Chair Jerome Powell put a lump of coal in markets’ Christmas stocking by signaling that sticky inflation means investors shouldn’t expect deep rate cuts next year. Futures tracking the Dow Jones Industrial Average climbed 194 points, or 0.5%. All three indexes had plummeted on Wednesday, with Powell’s hawkish presser sinking the Dow by 1,100 points to lock in its longest losing streak in half a century.

Barrons.com 29 minutes ago

^DJI

^GSPC
US Stocks Poised to Bounce Back After Fed Jolt: Markets Wrap

(Bloomberg) -- US stocks are set for a partial recovery on Thursday, suggesting the selloff after the Federal Reserve’s hawkish pivot was overdone. The yen slid as the Bank of Japan left borrowing costs unchanged.Most Read from BloombergNYPD Car Chases Are Becoming More Frequent — and More DangerousFutures contracts for the S&P 500 advanced 0.5% following the US benchmark’s biggest lost for a scheduled Fed decision day since 2001. Nasdaq 100 contracts rose 0.4%. Key gauges in Europe and Asia ret

Bloomberg 33 minutes ago

^GSPC
These Stocks Are Moving the Most Today: Micron, Tesla, Lennar, Quantum Computing, Palantir, Lamb Weston, FedEx, and More

Micron stock tumbles after the maker of memory chips issues a weak second-quarter outlook, Tesla shares claw back some losses from Wednesday, and Lennar’s quarterly earnings and revenue fall from a year earlier. FedEx and Nike are scheduled to report earnings later Thursday.

Barrons.com 49 minutes ago

FDX

MU

LEN-B
Stock Market’s Fed Reaction Is Overdone. But New Year Cheer Is Still Unlikely.

Trump demands clean extension to government funding after push back, TikTok will argue its case against ban in Supreme Court, and more news to start your day.

Barrons.com 58 minutes ago

COMP

^GSPC

^DJI
Why Wall Street Is Tumbling Today?

US Equities Dive as Recession Fears Spark Broad Sell-Off

GuruFocus.com 1 hour ago

COMP

^GSPC

^DJI
Mesoblast's Cell Therapy Treatment For Graft Versus Host Disease Gets FDA Approval, Stock Surges

On Wednesday, the FDA approved Mesoblast Limited’s (NASDAQ:MESO) Ryoncil (remestemcel-L) as the first mesenchymal stromal cell (MSC) therapy in the U.S. Ryoncil is the only MSC therapy approved in the U.S. for any indication and the only therapy for steroid-refractory acute graft versus host disease (SR-aGvHD) in children 2 months and older, including adolescents. Ryoncil contains MSCs, a type of cell that can have various roles in the body and can differentiate into multiple other types of cell

Benzinga 1 hour ago

MSB.AX
Trending tickers: Nvidia, Micron, Coinbase, Nissan and Severn Trent

The latest investor updates on stocks that are trending on Thursday.

Yahoo Finance UK 1 hour ago

CCL

CUK

CUKPF
Snow Lake Energy Announces Pricing of Public Offering

Winnipeg, Manitoba--(Newsfile Corp. - December 19, 2024) - Snow Lake Resources Ltd., d/b/a Snow Lake Energy (NASDAQ: LITM) ("Snow Lake" or the "Company"), a uranium exploration company, today announced the pricing of a best efforts public offering of 15,750,000 common shares at a public offering price of $0.41 per share, for gross proceeds of approximately $6.45 million, before deducting placement agent fees and offering expenses. All of the common shares are being offered by ...

Newsfile 1 hour ago

LITM

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

SGALPBE@RC2507A (10497.HK)

Related News

Stock market today: Dow, S&P 500, Nasdaq futures point to rebound from Fed-fueled rout

Fed cuts rates by quarter point, scales back cuts for 2025

Stock market today: Dow, S&P 500, Nasdaq clobbered as Fed, Powell signal fewer rate cuts in 2025

Your 2025 portfolio strategy can't rely on more rate cuts: Strategist

Dow, S&P 500, Nasdaq sell off after Fed's 25 bps cut

Why this strategist sees a 'multi-month pause' from the Fed

Oklo strikes nuclear power deal with Switch, stock jumps

Biden reignites talk of a stock-trading ban for lawmakers. Familiar hurdles remain.

Fed rate decision, Dow pressured, Nissan-Honda: 3 Things

Micron downgraded at BofA on gross margin, pricing headwinds

Cognition Therapeutics announces results in Phase 2 study of CT1812

Vertex Non-Opioid Drug Doesn't Best Placebo In Back Pain Study. The Stock Is Plunging.

Dow Rebounding After Fed Scare Triggers Huge Selloff. Index on 10-Day Losing Streak.

US Stocks Poised to Bounce Back After Fed Jolt: Markets Wrap

These Stocks Are Moving the Most Today: Micron, Tesla, Lennar, Quantum Computing, Palantir, Lamb Weston, FedEx, and More

Stock Market’s Fed Reaction Is Overdone. But New Year Cheer Is Still Unlikely.

Why Wall Street Is Tumbling Today?

Mesoblast's Cell Therapy Treatment For Graft Versus Host Disease Gets FDA Approval, Stock Surges

Trending tickers: Nvidia, Micron, Coinbase, Nissan and Severn Trent

Snow Lake Energy Announces Pricing of Public Offering